Development and Evaluation of a Novel Inhalable Liposomal Powder Co-Encapsulating ASSNAC and Pirfenidone via Spray Freeze-Drying for Targeted Pulmonary Fibrosis Therapy.
- DOI
- 10.3390/ph19091374
- Published
- 2026 Aug 31
- Container
- Pharmaceuticals (Basel, Switzerland)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/ph19091374,
title = {Development and Evaluation of a Novel Inhalable Liposomal Powder Co-Encapsulating ASSNAC and Pirfenidone via Spray Freeze-Drying for Targeted Pulmonary Fibrosis Therapy.},
author = {Zhang Q and Sun S and Lu M and Qin R and Ren J and Yao L and Jia D and Chang J and Chu X and Wang R and Liu F and Li J},
year = {2026},
journal = {Pharmaceuticals (Basel, Switzerland)},
doi = {10.3390/ph19091374},
url = {https://doi.org/10.3390/ph19091374}
}RIS
TY - JOUR TI - Development and Evaluation of a Novel Inhalable Liposomal Powder Co-Encapsulating ASSNAC and Pirfenidone via Spray Freeze-Drying for Targeted Pulmonary Fibrosis Therapy. AU - Zhang Q AU - Sun S AU - Lu M AU - Qin R AU - Ren J AU - Yao L AU - Jia D AU - Chang J AU - Chu X AU - Wang R AU - Liu F AU - Li J PY - 2026 JO - Pharmaceuticals (Basel, Switzerland) DO - 10.3390/ph19091374 UR - https://doi.org/10.3390/ph19091374 ER -
APA
Q, Z., S, S., M, L., R, Q., J, R., L, Y., D, J., J, C., X, C., R, W., F, L., & J, L. (2026). Development and Evaluation of a Novel Inhalable Liposomal Powder Co-Encapsulating ASSNAC and Pirfenidone via Spray Freeze-Drying for Targeted Pulmonary Fibrosis Therapy.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph19091374
Source records
- pubmed · retrieved 2026-09-26T20:16:02.117Z